OPENING OF BANKRUPTCY

Oncomfort

Export PDF

Company — Opening of bankruptcy.

Financial year 2021 · Closed on 31/12/2021

Net result-1,6 M €-38,5 %over 1 year

Gross margin-490,8 k €+39,5 %over 1 year

Equity4,1 M €+657,8 %over 1 year

Identity

Source · BCE/KBO

Oncomfort is a Public limited company incorporated in 2017. Its main activity is: Computer programming activities. Its registered office is in Wavre.

Legal situation: Opening of bankruptcy
BCE/KBO no. / VAT: BE 0674.419.521
Incorporation: 11/04/2017
Legal form: Public limited company
Registered office: Avenue Einstein 16 box 12
1300 Wavre · WallonieSee on map
Contributed capital: 7 988 711,80 €
Latest accounts: 31/12/2021

Activities (NACE)

62010Computer programming activities· main 62100Computer programming, consultancy and related activities 62020Computer consultancy activities 62090Other information technology and computer service activities 62200Computer programming, consultancy and related activities 62900Computer programming, consultancy and related activities

Joint committees (3)

Signals

Solid equityGood liquidityHealthy social debts

Financials

Source · NBB, 4 filings

Trend over 3 financial years

	2021		2019		2018
Income statement
Gross margin	-490,8 k €	+39.5%	-811 k €	+15.8%	-963,7 k €
EBITDA	-1,3 M €	-14.8%	-1,1 M €	+13.7%	-1,3 M €
Operating result	-1,6 M €	-40.6%	-1,1 M €	+22.8%	-1,5 M €
Net result	-1,6 M €	-38.5%	-1,2 M €	+25.1%	-1,5 M €
Balance sheet
Equity	4,1 M €	+658%	-736,3 k €	-275%	420 k €
Total assets	5,3 M €	+252%	1,5 M €	+53.9%	977,6 k €
Cash	2,9 M €	+154%	1,1 M €	+56.5%	734,1 k €
Debts	656,1 k €	-68.3%	2,1 M €	+397%	416,2 k €
Other
Workforce	–		4,0 ETP	+48.1%	2,7 ETP

Board of directors

Source · NBB, accounts to 31/12/2021

6 active · 4 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
TRANSFORM MEDICAL GMBHRepresented by Kar SCHWEITZER	Director15/12/2021 → 07/06/2027
CREDIT MUTUEL INNOVATIONRepresented by Delphine CARDI	Director08/09/2020 → 02/06/2026
DEBIOPHARM INNOVATION FUNDRepresented by Tanja Dowe	Director08/09/2020 → 02/06/2026
ARIOM0808.233.593Represented by Mario Huyghe	Managing director01/10/2018 → 04/06/2024
Jérôme MAJOIE	Director26/09/2018 → 04/06/2024
Diane Jooris	Director11/04/2017 → 07/06/2022

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
CREDIT MUTUEL INNOVATION0756.981.070Represented by Delphine CARDI	Director08/09/2020 → 2020 accounts
DEBIOPHARM INNOVATION FUND0756.981.466Represented by Tanja DOWE	Director08/09/2020 → 2020 accounts
Lieve Grawet	Director26/09/2018 → 2019 accounts
Gérald de Patoul	Director11/04/2017 → 2019 accounts

Other companies at this address

Avenue Einstein 16 1300 Wavre

Company	CBE no.
CECAMA● Active	0888.953.827
INTERNATIONAL SOURCING GROUP● Active	0536.459.686
MOVING PEOPLE● Active	0873.678.208

Full financial information

Source · NBB

	2021	2020	2019	2018
Type of account	Micro model	Micro model	Abridged model	Abridged model
Start of the financial year	01/01/2021	01/01/2020	01/01/2019	07/04/2017
Closing of the financial year	31/12/2021	31/12/2020	31/12/2019	31/12/2018
Length of the financial year	12 months	12 months	12 months	21 months
Filing date	05/09/2022	30/06/2021	02/06/2020	21/06/2019
General meeting	22/06/2022	07/06/2021	04/05/2020	04/06/2019
Currency of the financial year	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 4 filings

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2021	22/06/2022	05/09/2022	French	PDF
Micro model	31/12/2020	07/06/2021	30/06/2021	French	PDF
Abridged model	31/12/2019	04/05/2020	02/06/2020	French	PDF
Abridged model	31/12/2018	04/06/2019	21/06/2019	French	PDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2021

6 active · 4 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
TRANSFORM MEDICAL GMBHRepresented by Kar SCHWEITZER	Director15/12/2021 → 07/06/2027
CREDIT MUTUEL INNOVATIONRepresented by Delphine CARDI	Director08/09/2020 → 02/06/2026
DEBIOPHARM INNOVATION FUNDRepresented by Tanja Dowe	Director08/09/2020 → 02/06/2026
ARIOM0808.233.593Represented by Mario Huyghe	Managing director01/10/2018 → 04/06/2024
Jérôme MAJOIE	Director26/09/2018 → 04/06/2024
Diane Jooris	Director11/04/2017 → 07/06/2022

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
CREDIT MUTUEL INNOVATION0756.981.070Represented by Delphine CARDI	Director08/09/2020 → 2020 accounts
DEBIOPHARM INNOVATION FUND0756.981.466Represented by Tanja DOWE	Director08/09/2020 → 2020 accounts
Lieve Grawet	Director26/09/2018 → 2019 accounts
Gérald de Patoul	Director11/04/2017 → 2019 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates12/12/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates25/10/2022
CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
PDF
Mandates26/09/2022
SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF
Mandates17/06/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates10/03/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates12/11/2020
CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Capital / shares05/11/2020
CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates20/05/2020
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings3 filings

Mandates

TRANSFORM MEDICAL GMBH

CREDIT MUTUEL INNOVATION

DEBIOPHARM INNOVATION FUND

ARIOM

Jérôme MAJOIE

Diane Jooris

CREDIT MUTUEL INNOVATION

DEBIOPHARM INNOVATION FUND

Lieve Grawet

Gérald de Patoul

20172018201920202021202220232024202520262027

Oncomfort

Director

Managing director

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Avenue Einstein 16 bte 12, 1300 WavreCurrent		CBE
Chaussée de Louvain 172, 1300 Wavre	accounts 2021	Accounts 2021 · 2022-20417488

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
OncomfortCurrent	accounts 2018 → 2021	Accounts 2021 · 2022-20417488

Events

2021
Annual accounts 2021-1,6 M €↓
2019
Annual accounts 2019-1,2 M €↑
2018
Annual accounts 2018-1,5 M €
11/04/2017
IncorporationPublic limited company

Oncomfort

Overview

Identity

Financials

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events